Status:
UNKNOWN
Personalized, Predictive, Precise & Preventive Medicine for Major Depression
Lead Sponsor:
Hannover Medical School
Collaborating Sponsors:
University Medicine Greifswald
Wuerzburg University Hospital
Conditions:
Major Depressive Disorder
Persistent Depressive Disorder
Eligibility:
All Genders
18-70 years
Brief Summary
Depressive disorders are among the most common psychiatric disorders. However, this disorder is multifaceted, as are its etiological factors, and is not yet fully understood. Within the framework of t...
Eligibility Criteria
Inclusion
- MDD: ICD-10: F32.1-3, F33.1-3 first or recurrent depressive episode (confirmed by MINI-DIPS) and/or PDD: F34.1
- Symptom severity: Moderate to severe (MADRS ≥ 20).
- First depressive episode before 50 years of age
- Signed informed consent form
- Capacity to consent
Exclusion
- Acute Suicidality
- Placement according to state law (e.g. §16/17 Nds. PsychKG)
- The following diagnoses in the life course: Dementia, schizophrenia, schizoaffective disorder, bipolar disorder, substance dependence with currently necessary detoxification
- Concurrent participation in other clinical trials that are not being conducted within the framework of the P4D project
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06027177
Start Date
September 1 2023
End Date
August 1 2025
Last Update
September 7 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.